Global Urinary Tract Infection Market Research and Forecast, 2018-2023
Global urinary tract infection (UTI) treatment market is expected to grow significantly during the forecast period (2018-2023). A UTI treatment is an infection caused by microbes such as bacteria, fungi, and viruses that can occur in any urinary system such as kidneys, ureters, bladder, and urethra. Global UTI treatment market is significantly emerging due to various factors such as the growing geriatric population. The increasing prevalence of obesity & diabetes and rising incidences of immune suppression accompanied by urologic abnormality due to consumption of unhealthy food, alcohol, and smoking also drive the market growth. Availability of generic drugs helps the expansion of the segment.
Factors such as emerging economies, modernization of healthcare across the globe, and innovative technologies which lead to the introduction of new treatments and drugs create a future opportunity for market growth. However, there are certain factors which hinder the growth of the market such as the lack of awareness among people and strict government regulations.
Geographically, the global UTI treatment market is divided into North America, Europe, Asia-Pacific and Rest of the world. North America is estimated to hold a significant share in the global market due to a high prevalence rate of urinary tract infection. In addition, the region has a well-developed healthcare infrastructure that also contributes to the growth of the market in the region. Europe has considerable market share with better reimbursement policies and the introduction of new drugs in the market.
The major players operating in the market that are bringing innovation and improvement in the treatment and drugs of the disease include Siemens Healthineers, Beckman Coulter Inc., Sysmex Corporation, Arkray Inc., Acon Laboratories, Becton Dickinson and Company, and Biomerieux SA. These players are adopting various strategies to enhance their market value and strengthen their presence globally.
RESEARCH METHODOLOGY
The market study of UTI treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, a country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
SECONDARY SOURCES INCLUDE:
MARKET SEGMENTATION:
Global UTI treatment market is segmented on the basis of regional outlook and following segments:
Global UTI treatment Market Research and Analysis, By Test Type
Global UTI treatment Market Research and Analysis, By Indication
Global UTI treatment Market Research and Analysis, By End-User
Global UTI Market Research and Analysis, By Region
THE REPORT COVERS:
Factors such as emerging economies, modernization of healthcare across the globe, and innovative technologies which lead to the introduction of new treatments and drugs create a future opportunity for market growth. However, there are certain factors which hinder the growth of the market such as the lack of awareness among people and strict government regulations.
Geographically, the global UTI treatment market is divided into North America, Europe, Asia-Pacific and Rest of the world. North America is estimated to hold a significant share in the global market due to a high prevalence rate of urinary tract infection. In addition, the region has a well-developed healthcare infrastructure that also contributes to the growth of the market in the region. Europe has considerable market share with better reimbursement policies and the introduction of new drugs in the market.
The major players operating in the market that are bringing innovation and improvement in the treatment and drugs of the disease include Siemens Healthineers, Beckman Coulter Inc., Sysmex Corporation, Arkray Inc., Acon Laboratories, Becton Dickinson and Company, and Biomerieux SA. These players are adopting various strategies to enhance their market value and strengthen their presence globally.
RESEARCH METHODOLOGY
The market study of UTI treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, a country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
SECONDARY SOURCES INCLUDE:
- Financial reports of companies involved in the market
- Authentic Public Databases such WHO.
- Whitepapers, research-papers and news blogs
- Company websites and their product catalog.
MARKET SEGMENTATION:
Global UTI treatment market is segmented on the basis of regional outlook and following segments:
Global UTI treatment Market Research and Analysis, By Test Type
Global UTI treatment Market Research and Analysis, By Indication
Global UTI treatment Market Research and Analysis, By End-User
Global UTI Market Research and Analysis, By Region
THE REPORT COVERS:
- Comprehensive research methodology of global UTI treatment
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global UTI treatment market.
- Insights about market determinants which are stimulating the global UTI treatment
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1. REPORT SUMMARY
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insights &Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Rules & Regulations
3. MARKET DETERMINANTS
3.1. Motivators
3.1.1. Increasing Prevalence of Obesity, Diabetes and Kidney Stones
3.1.2. Rising Incidences of Immune Suppression and Urologic Abnormality
3.1.3. Introduction of New Drugs
3.2. Restraints
3.2.1. Lack of Awareness Among People
3.2.2. Stringent Government Regulations
3.3. Opportunities
3.3.1. Innovation in Technology Such as Smart Urinary Tract Infection Devices
4. MARKET SEGMENTATION
4.1. Market Breakdown by Test Type
4.1.1. Biochemical Urinary Tract Infection
4.1.2. Microscopic Urinary Tract Infection
4.1.3. Flow Cytometric Urinary Tract Infection
4.2. Market Breakdown by Indication
4.2.1. Complicated Urinary Tract Infection
4.2.2. Uncomplicated Urinary Tract Infection
4.2.3. Neurogenic Bladder Infections
4.3. Market Breakdown by End-User
4.3.1. Hospitals and Clinics
4.3.2. Home Healthcare
5. COMPETITIVE LANDSCAPE
5.1. Key Company Analysis
5.2. Key Strategy Analysis
6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. RoE
6.3. Asia-Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of The World
7. COMPANY PROFILES
7.1. Acon Laboratories, Inc.
7.2. Actavis Generics
7.3. Arkray Inc.
7.4. AstraZeneca PLC
7.5. Bayers AG
7.6. Beckman Coulter Inc.
7.7. Becton, Dickinson And Company
7.8. Biomerieux S.A.
7.9. Bio-Rad Laboratories Inc.
7.10. Biotronik Inc.
7.11. Boehringer Ingelheim GmbH
7.12. F. Hoffmann-La Roche Ltd.
7.13. GlaxoSmithKline PLC
7.14. Novartis International AG
7.15. Pfizer Inc.
7.16. Sanofi S.A.
7.17. Siemens AG
7.18. Synergy Health PLC
7.19. Sysmex Corp.
7.20. Teva Pharmaceutical Industries Ltd.
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insights &Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Rules & Regulations
3. MARKET DETERMINANTS
3.1. Motivators
3.1.1. Increasing Prevalence of Obesity, Diabetes and Kidney Stones
3.1.2. Rising Incidences of Immune Suppression and Urologic Abnormality
3.1.3. Introduction of New Drugs
3.2. Restraints
3.2.1. Lack of Awareness Among People
3.2.2. Stringent Government Regulations
3.3. Opportunities
3.3.1. Innovation in Technology Such as Smart Urinary Tract Infection Devices
4. MARKET SEGMENTATION
4.1. Market Breakdown by Test Type
4.1.1. Biochemical Urinary Tract Infection
4.1.2. Microscopic Urinary Tract Infection
4.1.3. Flow Cytometric Urinary Tract Infection
4.2. Market Breakdown by Indication
4.2.1. Complicated Urinary Tract Infection
4.2.2. Uncomplicated Urinary Tract Infection
4.2.3. Neurogenic Bladder Infections
4.3. Market Breakdown by End-User
4.3.1. Hospitals and Clinics
4.3.2. Home Healthcare
5. COMPETITIVE LANDSCAPE
5.1. Key Company Analysis
5.2. Key Strategy Analysis
6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. RoE
6.3. Asia-Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of The World
7. COMPANY PROFILES
7.1. Acon Laboratories, Inc.
7.2. Actavis Generics
7.3. Arkray Inc.
7.4. AstraZeneca PLC
7.5. Bayers AG
7.6. Beckman Coulter Inc.
7.7. Becton, Dickinson And Company
7.8. Biomerieux S.A.
7.9. Bio-Rad Laboratories Inc.
7.10. Biotronik Inc.
7.11. Boehringer Ingelheim GmbH
7.12. F. Hoffmann-La Roche Ltd.
7.13. GlaxoSmithKline PLC
7.14. Novartis International AG
7.15. Pfizer Inc.
7.16. Sanofi S.A.
7.17. Siemens AG
7.18. Synergy Health PLC
7.19. Sysmex Corp.
7.20. Teva Pharmaceutical Industries Ltd.
LIST OF TABLES
TABLE # 1 GLOBAL URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL BIOCHEMICAL URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL MICROSCOPIC URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL FLOW CYTOMETRIC URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY INDICATION, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL COMPLICATED URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL UNCOMPLICATED URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL NEUROGENIC BLADDER INFECTIONS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL HOME HEALTHCARE MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 12 NORTH AMERICA URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 13 NORTH AMERICA URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2017-2023 ($ MILLION)
TABLE # 14 NORTH AMERICA URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY INDICATION, 2017-2023 ($ MILLION)
TABLE # 15 NORTH AMERICA URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 16 EUROPE URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 17 EUROPE URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2017-2023 ($ MILLION)
TABLE # 18 EUROPE URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY INDICATION, 2017-2023 ($ MILLION)
TABLE # 19 EUROPE URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 20 ASIA-PACIFIC URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 21 ASIA-PACIFIC URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2017-2023 ($ MILLION)
TABLE # 22 ASIA-PACIFIC URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY INDICATION, 2017-2023 ($ MILLION)
TABLE # 23 ASIA-PACIFIC URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 24 REST OF THE WORLD URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2017-2023 ($ MILLION)
TABLE # 25 REST OF THE WORLD URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY INDICATION, 2017-2023 ($ MILLION)
TABLE # 26 REST OF THE WORLD URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 1 GLOBAL URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL BIOCHEMICAL URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL MICROSCOPIC URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL FLOW CYTOMETRIC URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY INDICATION, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL COMPLICATED URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL UNCOMPLICATED URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL NEUROGENIC BLADDER INFECTIONS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL HOME HEALTHCARE MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 12 NORTH AMERICA URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 13 NORTH AMERICA URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2017-2023 ($ MILLION)
TABLE # 14 NORTH AMERICA URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY INDICATION, 2017-2023 ($ MILLION)
TABLE # 15 NORTH AMERICA URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 16 EUROPE URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 17 EUROPE URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2017-2023 ($ MILLION)
TABLE # 18 EUROPE URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY INDICATION, 2017-2023 ($ MILLION)
TABLE # 19 EUROPE URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 20 ASIA-PACIFIC URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 21 ASIA-PACIFIC URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2017-2023 ($ MILLION)
TABLE # 22 ASIA-PACIFIC URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY INDICATION, 2017-2023 ($ MILLION)
TABLE # 23 ASIA-PACIFIC URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 24 REST OF THE WORLD URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2017-2023 ($ MILLION)
TABLE # 25 REST OF THE WORLD URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY INDICATION, 2017-2023 ($ MILLION)
TABLE # 26 REST OF THE WORLD URINARY TRACT INFECTION MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
LIST OF FIGURES
FIGURE # 1 GLOBAL URINARY TRACT INFECTION MARKET SHARE BY TEST TYPE, 2017 VS 2023 (IN %)
FIGURE # 2 GLOBAL URINARY TRACT INFECTION MARKET SHARE BY INDICATION, 2017 VS 2023 (IN %)
FIGURE # 3 GLOBAL URINARY TRACT INFECTION MARKET SHARE BY END-USER, 2017 VS 2023 (IN %)
FIGURE # 4 GLOBAL URINARY TRACT INFECTION MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (IN %)
FIGURE # 5 US URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 6 CANADA URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 7 UK URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 8 FRANCE URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 9 GERMANY URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 10 ITALY URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 11 SPAIN URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 12 ROE URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 13 INDIA URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 14 CHINA URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 15 JAPAN URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 16 REST OF ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 17 REST OF THE WORLD URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 1 GLOBAL URINARY TRACT INFECTION MARKET SHARE BY TEST TYPE, 2017 VS 2023 (IN %)
FIGURE # 2 GLOBAL URINARY TRACT INFECTION MARKET SHARE BY INDICATION, 2017 VS 2023 (IN %)
FIGURE # 3 GLOBAL URINARY TRACT INFECTION MARKET SHARE BY END-USER, 2017 VS 2023 (IN %)
FIGURE # 4 GLOBAL URINARY TRACT INFECTION MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (IN %)
FIGURE # 5 US URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 6 CANADA URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 7 UK URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 8 FRANCE URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 9 GERMANY URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 10 ITALY URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 11 SPAIN URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 12 ROE URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 13 INDIA URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 14 CHINA URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 15 JAPAN URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 16 REST OF ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
FIGURE # 17 REST OF THE WORLD URINARY TRACT INFECTION MARKET SIZE, 2017-2023 ($MILLION)
